Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Ron Alfa
Angel
Overview
- Gender
- male
- Investor Type
- Angel
Ron Alfa is Vice President, Discovery and Product at Recursion Pharmaceuticals where he manages scientific product development and external alliances across Recursion’s AI-enabled discovery platform. Ron Alfa’s scientific contributions prior to Recursion span Neurosciences, Metabolism, and Genetics.
Personal Investments
Number of Investments
1
Ron Alfa has made 1 investments. Their most recent investment was on
Dec 6, 2022, when Infinimmune raised $12M.
| Date | Company Name | Round | Money Raised | Industry | |
|---|---|---|---|---|---|
| Dec 6, 2022 |
Infinimmune
|
Seed | $12M | Biotechnology | Detail |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
